CYTOKINETICS, INCORPORATED Quotes Cytokinetics, Incorporated Deutsche Boerse AG
Equities
KK3A
US23282W6057
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45 EUR | -0.44% |
|
+1.35% | -39.19% |
| 05-29 | Truist Securities Lowers Price Target on Cytokinetics to $70 From $86, Maintains Buy Rating | MT |
| 05-28 | Cytokinetics Closes $500 Million Stock Offering | MT |
Quotes 5-day view
Delayed Quote Deutsche Boerse AG| 28/05/2024 | 29/05/2024 | 30/05/2024 | 31/05/2024 | |
|---|---|---|---|---|
| Last | 44.2 € | 44.2 € | 45.2 € | 45 € |
| Volume | 0 | 0 | 0 | 0 |
| Change | +0.45% | -.--% | +2.26% | -0.44% |
| Opening | 44.00 | 43.80 | 43.40 | 45.00 |
| High | 44.20 | 44.20 | 45.20 | 45.00 |
| Low | 44.00 | 43.80 | 43.40 | 45.00 |
Performance
| 1 day | -0.44% | ||
| 1 week | +1.35% | ||
| 1 month | -21.05% | ||
| 3 months | -33.33% | ||
| 6 months | +48.03% | ||
| Current year | -39.19% | ||
| 1 year | +27.12% | ||
| 3 years | +151.40% | ||
| 5 years | +403.75% | ||
| 10 years | +1,093.32% |
Volumes
marketsCapital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
5 565 695 986
Capitalization (USD)
5 565 695 986
Net sales (USD)
7 530 000
Number of employees
423
Sales / Employee (USD)
17 801
Free-Float
99.45 %
Free-Float capitalization (EUR)
5 994 982 291
Free-Float capitalization (USD)
5 527 877 250
Average Daily Capital Traded
0%
Highs and lows
1 week
43.40
45.20
1 month
43.4060.50
Current year
43.4099.50
1 year
25.2099.50
3 years
15.3099.50
5 years
7.1099.50
10 years
2.4799.50
Indicators
Moving average 5 days
44.52
Moving average 20 days
53.10
Moving average 50 days
59.30
Moving average 100 days
64.59
Price spread / (MMA5)
-1.07%
Price spread / (MMA20)
+17.99%
Price spread / (MMA50)
+31.77%
Price spread / (MMA100)
+43.53%
STIM
RSI 9 days
23.23
RSI 14 days
25.17
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -0.44% | +1.35% | -39.19% | +27.12% | 5.57B | ||
| +1.06% | -0.49% | +11.60% | +34.05% | 106B | ||
| +1.87% | +3.76% | -4.68% | -3.38% | 24.28B | ||
| +1.04% | +0.89% | -0.82% | -6.84% | 21.96B | ||
| +0.31% | +0.55% | -10.12% | -29.18% | 18.16B | ||
| +0.41% | -1.50% | -42.12% | -37.24% | 16.37B | ||
| -3.50% | -2.53% | -17.47% | -33.39% | 15.56B | ||
| -0.91% | -2.86% | +2.77% | +48.49% | 13.63B | ||
| +4.28% | +5.12% | +34.58% | +4.43% | 12.27B | ||
| -3.39% | +150.23% | +77.64% | +186.12% | 8.87B | ||
| -1.71% | +3.60% | +7.26% | +53.59% | 7.75B | ||
| +0.09% | +2.20% | +11.89% | +39.70% | 7.65B | ||
| +0.25% | -1.43% | -3.92% | +25.16% | 7.42B | ||
| -7.66% | -3.38% | -33.51% | -37.11% | 7.29B | ||
| +0.78% | -0.78% | +234.55% | +183.39% | 6.87B | ||
| +4.40% | +5.47% | -9.57% | +11.89% | 6.32B | ||
| Average | -0.20% | +10.64% | +13.68% | +29.17% | ||
| Weighted average by Cap. | +0.39% | +5.04% | +8.07% | +21.69% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -39.19% | ||
| 2023 | +76.19% | ||
| 2022 | +3.45% | ||
| 2021 | +143.11% | ||
| 2020 | +84.53% | ||
| 2019 | +68.84% | ||
| 2018 | -22.87% | ||
| 2017 | -41.33% | ||
| 2016 | +23.90% | ||
| 2015 | +69.49% | ||
| 2014 | +17.48% | ||
| 2013 | +60.03% | ||
| 2012 | -32.16% | ||
| 2011 | -51.19% | ||
| 2010 | -19.25% | ||
| 2009 | +8.09% | ||
| 2008 | -48.97% | ||
| 2007 | -36.87% | ||
| 2006 | +32.27% |
- Stock Market
- Equities
- CYTK Stock
- KK3A Stock
- Quotes Cytokinetics, Incorporated
